FDA Guidance titled “Further Testing of Donations that are Reactive on a Licensed Donor Screening Test for Antibodies to Hepatitis C Virus; Guidance for Industry” was released on October 2, 2019 and recommends that CTS modify our current HCV reflex testing algorithm to support these best practices. The new algorithm will take effect on April 20, 2020.
Check out the Communication page for the complete details by clicking the link: Communications
On September 23, 2019, the new CTS Laboratory Information System successfully implemented in Da...
In response to the FDA guidance document for Babesia, CTS will implement the licensed Grifols ...
On May 9, 2019 the Food and Drug Administration issued a “Recommendations for Reducing the Ris...
The CTS 2020 Annual Laboratory Survey is on its way to your email box. We would appreciate you takin...
As previously mentioned in Zika communications distributed on September 21 and October 12, 2018; ord...
As winter weather continues to move through parts of the US, we would like to remind you it may be n...